Abstract:In recent years, several noncanonical RNA caps derived from cofactors and metabolites have been identified. Purine-containing RNA caps have been extensively studied, with multiple decapping enzymes identified and efficient capture and sequencing protocols developed for nicotinamide adenine dinucleotide (NAD)-RNA, which allowed for a stepwise elucidation of capping functions. Despite being identified as an abundant noncanonical RNA-cap, UDP-sugar-capped RNA remains poorly understood, which is partly due to its complex in vitro preparation. Here, we describe a scalable synthesis of sugar-capped uridine-guanosine dinucleotides from readily available protected building blocks and their enzymatic conversion into several cell wall precursor-capped dinucleotides. We employed these capped dinucleotides in T7 RNA polymerase-catalyzed in vitro transcription reactions to efficiently generate RNAs capped with uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), its N-azidoacetyl derivative UDP-GlcNAz, and various cell wall precursors. We furthermore identified four enzymes capable of processing UDP-GlcNAc-capped RNA in vitro: MurA, MurB and MurC from Escherichia coli can sequentially modify the sugar-cap structure and were used to introduce a bioorthogonal, clickable moiety, and the human Nudix hydrolase Nudt5 was shown to efficiently decap UDP-GlcNAc-RNA. Our findings underscore the importance of efficient synthetic methods for capped model RNAs. Additionally, we provide useful enzymatic tools that could be utilized in the development and application of UDP-GlcNAc capture and sequencing protocols. Such protocols are essential for deepening our understanding of the widespread yet enigmatic GlcNAc modification of RNA and its physiological significance.

Combining Chemical Synthesis and Enzymatic Methylation to Access Short RNAs with Various 5' Caps

Targeted Manipulation of Cellular RNA m6A Methylation at theSingle-Base Level br

Access to High-Purity 7m G-cap RNA in Substantial Quantities by a Convenient All-Chemical Solid-Phase Method

Access to capped RNAs by chemical ligation

Preparation of Human Nuclear RNA m⁶A Methyltransferases and Demethylases and Biochemical Characterization of Their Catalytic Activity.

Determining RNA Natural Modifications and Nucleoside Analog-Labeled Sites by a Chemical/Enzyme-Induced Base Mutation Principle

Chemical Synthesis of Modified RNA

Identification and in vitro characterization of UDP-GlcNAc-RNA cap-modifying and decapping enzymes

A general method for rapid and cost-efficient large-scale production of 5' capped RNA

Efficient preparation and properties of mRNAs containing a fluorescent cap analog: Anthraniloyl-m(7)GpppG

Selective 5' modification of T7 RNA polymerase transcripts

A Programmable System to Methylate and Demethylate N6-methyladenosine (m6a) on Specific RNA Transcripts in Mammalian Cells

Stabilized 5' Cap Analogue for Optochemical Activation of mRNA Translation

The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5′ cap modulates protein expression in living cells

Versatile strategy using vaccinia virus-capping enzyme to synthesize functional 5' cap-modified mRNAs

To cap it all off, again: dynamic capping and recapping of coding and non-coding RNAs to control transcript fate and biological activity

The cap epitranscriptome: Early directions to a complex life as mRNA

How Natural Enzymes and Synthetic Ribozymes Generate Methylated Nucleotides in RNA

A Programmable System to Methylate and Demethylate M6a on Specific Mrnas

Thg1 family 3’-5’ RNA polymerases as tools for targeted RNA synthesis

Site-specific RNA modification via initiation of in vitro transcription reactions with m6A and isomorphic emissive adenosine analogs